Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > What do people do every day at TLT without any patients
View:
Post by Galaxym31 on May 22, 2024 12:30pm

What do people do every day at TLT without any patients

being treated ? Wonder what the seven days a week cash burn is .
Comment by plantrader on May 22, 2024 7:33pm
That's not what I wonder. I wonder whether they'll tell us if they were unable to procure all the extra follow up data or whatever the deficiencies identified by the FDA were. Or will we have to wonder and guess with many more months of slightly indirect or unclear BTD updates? Will we know if their BTD application isn't approved by the FDA? The FDA only publishes the approvals, right? ...more  
Comment by menoalittle on May 22, 2024 8:08pm
>> Will we know if their BTD application isn't approved by the FDA? You're way out over your ski's on this one, bud. (because it hasn't yet been submitted...) Once they announce it has actually been submitted... this stock will rip higher. Wanna bet against me on that? Go for it, if you want. Ah, but what do I know... probably not much.
Comment by plantrader on May 22, 2024 9:54pm
Bet against you? We've all bet on the stock as it is. Reading comprehension, my question was how will we know if their BTD application is NOT approved? The FDA only publishes approvals, I believe. So, if the FDA decision is a "no" will the company tell us? Or will we have to extrapolate it due to the passage of time without info? If they get approval then the question is moot.   ...more  
Comment by Longholder99 on May 23, 2024 8:30am
I've been around on this bull board and have been holding TLT stock for many years.  There is an uncanny accuracy to menoalittle's statements and predictions.  I'm gonna lean their way on this and suggest that Theralase will announce the application.  Soon.  
Comment by Lesalpes29 on May 23, 2024 8:46am
If I was them I would put out the new about BTD application. To avoid speculation about it and say we are on track. But I know nothing about the whole process. GL
Comment by plantrader on May 23, 2024 9:00am
Normally I'd generically assume they'd announce the actual BTD "application" also, because for this seemingly struggling company it's a big deal. But two things... the company seems to be more keen on keeping specifics to themselves and we have numerous examples of that, and the industry standard seems to be to not announce "application". The latter I completely ...more  
Comment by DJDawg on May 23, 2024 10:46am
I agree that they won't announce BTD application itself. I do hope that they next patient data release does extend the swimmers plot past 450 days AND makes mention that the results were all validated by central lab. Those things would hint at the application being on track. Also, if the don't mention pre-BTD and only BTD one could guess that that means the pre-BTD feedback is in. I ...more  
Comment by Oilminerdeluxe on May 23, 2024 12:24pm
Hope you are right, DjDawg. Perhpas we will have to wait until the AGM is close before we hear anything, but I guess we are used to waiting. Any positive vibe would be most welcome. I hope they can adress stuff like how to get money if things drag out longer still. But let's not hope for that scenario. Shouldn't a Japanese or Korean entity be willing to cough of funds if they got a great ...more  
Comment by DJDawg on May 23, 2024 1:04pm
You mention AGM but are they not required to post quarterly filiing by May 30? That is the one that I'm hoping has some updates. A week today essentially.
Comment by Oilminerdeluxe on May 23, 2024 1:22pm
The earlier the better!
Comment by Pandora on May 23, 2024 3:57pm
Last year = May 30th: Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements Accesswire May 30, 2023 Theralase(R) Releases 1Q2023 Interim Financial Statements Accesswire May 30, 2023
Comment by Eoganacht on May 24, 2024 11:13am
Last year May 30 was a Tuesday.This year it's a Thursday. If there is good news they may decide to release earlier next week for better impact. They released the annual financial statements a month earlier than usual this year.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250